Author

Kristin Hammersbøen Bjørlykke

IMMUNOGENICITY AND SAFETY OF A THREE-DOSE SARS-COV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY
IMMUNOGENICITY AND SAFETY OF A THREE-DOSE SARS-COV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY

Kristin Hammersbøen Bjørlykke  et al.

COVID-19 OUTCOME AND ASSOCIATION TO ANTI-SPIKE ANTIBODY CONCENTRATIONS IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY; A PROSPECTIVE COHORT STUDY
COVID-19 OUTCOME AND ASSOCIATION TO ANTI-SPIKE ANTIBODY CONCENTRATIONS IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY; A PROSPECTIVE COHORT STUDY

Kristin Hammersbøen Bjørlykke  et al.

Item 1 - 2 / 2
1